Ulysses S. Torres
Hospital de Base
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ulysses S. Torres.
PLOS ONE | 2013
Fernando B. Rodrigues; Rosana G. Bruetto; Ulysses S. Torres; Ana Paula Otaviano; Dirce Maria Trevisan Zanetta; Emmanuel A. Burdmann
Background Acute kidney injury (AKI) increases the risk of death after acute myocardial infarction (AMI). Recently, a new AKI definition was proposed by the Kidney Disease Improving Global Outcomes (KDIGO) organization. The aim of the current study was to compare the incidence and the early and late mortality of AKI diagnosed by RIFLE and KDIGO criteria in the first 7 days of hospitalization due to an AMI. Methods and Results In total, 1,050 AMI patients were prospectively studied. AKI defined by RIFLE and KDIGO occurred in 14.8% and 36.6% of patients, respectively. By applying multivariate Cox analysis, AKI was associated with an increased adjusted hazard ratio (AHR) for 30-day death of 3.51 (95% confidence interval [CI] 2.35–5.25, p<0.001) by RIFLE and 3.99 (CI 2.59–6.15, p<0.001) by KDIGO and with an AHR for 1-year mortality of 1.84 (CI 1.12–3.01, p = 0.016) by RIFLE and 2.43 (CI 1.62–3.62, p<0.001) by KDIGO. The subgroup of patients diagnosed as non-AKI by RIFLE but as AKI by KDIGO criteria had also an increased AHR for death of 2.55 (1.52–4.28) at 30 days and 2.28 (CI 1.46–3.54) at 1 year (p<0.001). Conclusions KDIGO criteria detected substantially more AKI patients than RIFLE among AMI patients. Patients diagnosed as AKI by KDIGO but not RIFLE criteria had a significantly higher early and late mortality. In this study KDIGO criteria were more suitable for AKI diagnosis in AMI patients than RIFLE criteria.
Clinical Journal of The American Society of Nephrology | 2010
Fernando B. Rodrigues; Rosana G. Bruetto; Ulysses S. Torres; Ana Paula Otaviano; Dirce Maria Trevisan Zanetta; Emmanuel A. Burdmann
Chronic kidney disease (CKD) is highly prevalent worldwide and is associated with an increased risk for adverse outcomes in patients hospitalized with acute coronary syndrome (ACS). In studies including thousands of patients admitted with myocardial infarction, CKD consistently determines a poorer prognosis for ACS patients. In contrast with CKD, information about the effect of acute kidney injury (AKI) on clinical outcomes after ACS is limited. Most data come from retrospective registry databank studies of nonconsecutive patients with a significant number of patients excluded from analyses. There are no prospective studies designed to determine whether AKI strictly diagnosed by the new the Acute Kidney Injury Network (AKIN) or RIFLE (Risk, Injury, Failure, Loss, and End-stage kidney disease) criteria is a risk factor for death after ACS, and there are no data comparing the RIFLE and AKIN criteria for AKI diagnosis after myocardial infarction. This article reviews the most important data on CKD and ACS and the available data on AKI and ACS. The importance of obtaining an early serum creatinine level after admission for ACS and the importance of renal function monitoring during hospitalization are stressed.
PLOS ONE | 2012
Rosana G. Bruetto; Fernando B. Rodrigues; Ulysses S. Torres; Ana Paula Otaviano; Dirce Maria Trevisan Zanetta; Emmanuel A. Burdmann
Background The role of an impaired estimated glomerular filtration rate (eGFR) at hospital admission in the outcome of acute kidney injury (AKI) after acute myocardial infarction (AMI) has been underreported. The aim of this study was to assess the influence of an admission eGFR<60 mL/min/1.73 m2 on the incidence and early and late mortality of AMI-associated AKI. Methods A prospective study of 828 AMI patients was performed. AKI was defined as a serum creatinine increase of ≥50% from the time of admission (RIFLE criteria) in the first 7 days of hospitalization. Patients were divided into subgroups according to their eGFR upon hospital admission (MDRD formula, mL/min/1.73 m2) and the development of AKI: eGFR≥60 without AKI, eGFR<60 without AKI, eGFR≥60 with AKI and eGFR<60 with AKI. Results Overall, 14.6% of the patients in this study developed AKI. The admission eGFR had no impact on the incidence of AKI. However, the admission eGFR was associated with the outcome of AMI-associated AKI. The adjusted hazard ratios (AHR, Cox multivariate analysis) for 30-day mortality were 2.00 (95% CI 1.11–3.61) for eGFR<60 without AKI, 4.76 (95% CI 2.45–9.26) for eGFR≥60 with AKI and 6.27 (95% CI 3.20–12.29) for eGFR<60 with AKI. Only an admission eGFR of <60 with AKI was significantly associated with a 30-day to 1-year mortality hazard (AHR 3.05, 95% CI 1.50–6.19). Conclusions AKI development was associated with an increased early mortality hazard in AMI patients with either preserved or impaired admission eGFR. Only the association of impaired admission eGFR and AKI was associated with an increased hazard for late mortality among these patients.
Seminars in Ultrasound Ct and Mri | 2015
Ulysses S. Torres; Eduardo Portela-Oliveira; Fernanda Del Campo Braojos Braga; Heron Werner; Pedro Daltro; Antônio Soares Souza
Ventral body wall defects (VBWDs) are one of the main categories of human congenital malformations, representing a wide and heterogeneous group of defects sharing a common feature, that is, herniation of one or more viscera through a defect in the anterior body wall. Gastroschisis and omphalocele are the 2 most common congenital VBWDs. Other uncommon anomalies include ectopia cordis and pentalogy of Cantrell, limb-body wall complex, and bladder and cloacal exstrophy. Although VBWDs are associated with multiple abnormalities with distinct embryological origins and that may affect virtually any system organs, at least in relation to anterior body wall defects, they are thought (except for omphalocele) to share a common embryologic mechanism, that is, a failure involving the lateral body wall folds responsible for closing the thoracic, abdominal, and pelvic portions of the ventral body wall during the fourth week of development. Additionally, many of the principles of diagnosis and management are similar for these conditions. Fetal ultrasound (US) in prenatal care allows the diagnosis of most of such defects with subsequent opportunities for parental counseling and optimal perinatal management. Fetal magnetic resonance imaging may be an adjunct to US, providing global and detailed anatomical information, assessing the extent of defects, and also helping to confirm the diagnosis in equivocal cases. Prenatal imaging features of VBWDs may be complex and challenging, often requiring from the radiologist a high level of suspicion and familiarity with the imaging patterns. Because an appropriate management is dependent on an accurate diagnosis and assessment of defects, radiologists should be able to recognize and distinguish between the different VBWDs and their associated anomalies. In this article, we review the relevant embryology of VBWDs to facilitate understanding of the pathologic anatomy and diagnostic imaging approach. Features will be illustrated with prenatal US and magnetic resonance imaging and correlated with postnatal and clinical imaging.
PLOS ONE | 2013
Valdeci Hélio Floriano; Ulysses S. Torres; Antonio Ronaldo Spotti; José Roberto Lopes Ferraz-Filho; Waldir Antônio Tognola
Background and Purpose Differentiating between infectious and neoplastic focal brain lesions that are detected by conventional structural magnetic resonance imaging (MRI) may be a challenge in routine practice. Brain perfusion-weighted MRI (PWI) may be employed as a complementary non-invasive tool, providing relevant data on hemodynamic parameters, such as the degree of angiogenesis of lesions. We aimed to employ dynamic susceptibility contrast-enhanced perfusion MR imaging (DSC-MRI) to differentiate between infectious and neoplastic brain lesions by investigating brain microcirculation changes. Materials and Methods DSC-MRI perfusion studies of one hundred consecutive patients with non-cortical neoplastic (n = 54) and infectious (n = 46) lesions were retrospectively assessed. MRI examinations were performed using a 1.5-T scanner. A preload of paramagnetic contrast agent (gadolinium) was administered 30 seconds before acquisition of dynamic images, followed by a standard dose 10 seconds after starting imaging acquisitions. The relative cerebral blood volume (rCBV) values were determined by calculating the regional cerebral blood volume in the solid areas of lesions, normalized to that of the contralateral normal-appearing white matter. Discriminant analyses were performed to determine the cutoff point of rCBV values that would allow the differentiation of neoplastic from infectious lesions and to assess the corresponding diagnostic performance of rCBV when using this cutoff value. Results Neoplastic lesions had higher rCBV values (4.28±2.11) than infectious lesions (0.63±0.49) (p<0.001). When using an rCBV value <1.3 as the parameter to define infectious lesions, the sensitivity of the method was 97.8% and the specificity was 92.6%, with a positive predictive value of 91.8%, a negative predictive value of 98.0%, and an accuracy of 95.0%. Conclusion PWI is a useful complementary tool in distinguishing between infectious and neoplastic brain lesions; an elevated discriminatory value for diagnosis of infectious brain lesions was observed in this sample of patients when the rCBV cutoff value was set to 1.3.
Pediatric Neurology | 2014
Eduardo Portela-Oliveira; Ulysses S. Torres; Carmen Lucia Penteado Lancellotti; Antônio Soares Souza; José Roberto Lopes Ferraz-Filho
A previously healthy 3-year-old boy presented with a seizure. Examination and laboratory tests were unremarkable. Magnetic resonance imaging (MRI) of the brain revealed an intraventricular, nodular, 2.5 2.1-cm lesion in the right occipital horn with surrounding edema and intense enhancement after gadolinium injection (Fig 1). A complete macroscopic excision was achieved. Histopathological and immunohistochemical analyses suggested a papillary glioneuronal tumor (Fig 2). The child developed normally and remains well after 4 years.
Archivos De Bronconeumologia | 2013
Ulysses S. Torres; Eduardo Portela-Oliveira; Fernanda del Campo Braojos; Luciana Vargas Cardoso; Arthur Soares Souza
Intercostal hernia is a very rare disorder which is mainly described in the context of trauma or following thoracic surgery.1,2 Depending on their aetiology, intercostal hernias can be classified as acquired (traumatic, spontaneous or pathological) or congenital.2 Post-operative thoracic hernias are usually a result of inadequate closure of the chest wall.2 However, most patients present hernia of the lung,1,2 defined as a protrusion of lung tissue beyond the confines of the chest cavity.3 In contrast, the protrusion of soft tissue into the pleural cavity (inverted intercostal hernia) is extremely rare.1 Here we describe a case of this type, highlighting the findings observed on multidetector computed tomography (MDCT). A 45-year-old woman was admitted with a 10-day history of chest pain in the posterior part of the right side, with no other associated symptoms. Ten years earlier, she had undergone resection of the seventh rib due to a costal hemangioma. A MDCT was performed, which revealed the presence of a convex lens-shaped herniation and incarceration of soft tissue of the right posterior chest wall (subcutaneous fat layer and major rhomboid muscle) in the pleural cavity through a widened intercostal space between the
Jcr-journal of Clinical Rheumatology | 2011
Gisele Cristine Dyonísio Fernandes; Ulysses S. Torres; Elisete Funes; Roberto Acayaba de Toledo
This 33-year-old Guatemalan man presented to a medical mission camp with generalized bilateral knee pain and inability to extend his leg without pain. The 4-ft 11-in patient had mild scoliosis, increased elbow carrying angles, and hypoplastic patellae. He had had dysplasia of the nails with triangular lunulae since birth. The fingernails were absent on the first and second digits of both hands. His mother had had similar physical findings. He had not had regular medical care.
Reumatología Clínica | 2011
Gisele Cristine Dyonísio Fernandes; Ulysses S. Torres; Tatiane Ester Aidar Fernandes; Roberto Acayaba de Toledo
Reumatología Clínica | 2011
Gisele Cristine Dyonísio Fernandes; Ulysses S. Torres; Tatiane Ester Aidar Fernandes; Roberto Acayaba de Toledo